hemoregulatory peptide 5b has been researched along with Benign Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marshall, E | 1 |
| Aakvaag, A; Frostad, S; Kalland, T; Laerum, OD | 1 |
1 review(s) available for hemoregulatory peptide 5b and Benign Neoplasms
| Article | Year |
|---|---|
Haemopoietic stem cell inhibition: potential for dose intensification.
Topics: Antineoplastic Agents; Cell Cycle; Chemokine CCL4; Cytokines; Dose-Response Relationship, Drug; Growth Inhibitors; Hematopoietic Stem Cells; Humans; Macrophage Inflammatory Proteins; Monokines; Neoplasms; Oligopeptides; Pyrrolidonecarboxylic Acid | 1995 |
1 other study(ies) available for hemoregulatory peptide 5b and Benign Neoplasms
| Article | Year |
|---|---|
Hemoregulatory peptide (HP5b) dimer effects on normal and malignant cells in culture.
Topics: 3T3 Cells; Amino Acid Sequence; Animals; Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Breast Neoplasms; Carcinoma, Ductal, Breast; Cells, Cultured; Colony-Forming Units Assay; Female; Glioblastoma; Glioma; Hematopoietic Stem Cells; Interleukin-3; Lymphocyte Activation; Lymphocyte Subsets; Lymphoma; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Molecular Sequence Data; Neoplasms; Oligopeptides; Polymers; Pyrrolidonecarboxylic Acid; Tumor Cells, Cultured | 1993 |